Autolus Therapeutics (AUTL) Other Non Operating Income: 2017-2025
Historic Other Non Operating Income for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to -$911,000.
- Autolus Therapeutics' Other Non Operating Income rose 92.34% to -$911,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 247.79%. This contributed to the annual value of -$1.0 million for FY2024, which is 137.89% down from last year.
- Autolus Therapeutics' Other Non Operating Income amounted to -$911,000 in Q3 2025, which was down 160.73% from $1.5 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Other Non Operating Income high stood at $979.0 million for Q3 2021, and its period low was -$11.9 million during Q3 2024.
- Moreover, its 3-year median value for Other Non Operating Income was $782,000 (2023), whereas its average is $345,091.
- In the last 5 years, Autolus Therapeutics' Other Non Operating Income soared by 39,119.53% in 2021 and then crashed by 586.67% in 2024.
- Quarterly analysis of 5 years shows Autolus Therapeutics' Other Non Operating Income stood at -$86,000 in 2021, then surged by 7,369.77% to $6.3 million in 2022, then tumbled by 50.72% to $3.1 million in 2023, then skyrocketed by 270.01% to $11.4 million in 2024, then skyrocketed by 92.34% to -$911,000 in 2025.
- Its last three reported values are -$911,000 in Q3 2025, $1.5 million for Q2 2025, and $1.2 million during Q1 2025.